DrugPatentWatch Database Preview
Patent: 6,063,601
Summary for Patent: 6,063,601
| Title: | Chimaeric gene coding for a transit peptide and a heterologous peptide |
| Abstract: | Chimaeric DNA sequence which encodes: 1) a transit peptide of a cytoplasmic precursor of a chloroplast protein or polypeptide of a plant and 2) a protein or polypeptide that is heterologous to the transit peptide. The chimaeric DNA sequence can be used as a vector for transforming a plant cell so that a chimaeric precursor of the heterologous protein or polypeptide is produced in the cytoplasm of the cell and the chimaeric precursor then transports the heterologous protein or polypeptide in vivo into a chloroplast of the cell. |
| Inventor(s): | Herrera-Estrella; Luis (Ghent, BE), Van Den Broeck; Guidi (Ghent, BE), Van Montagu; Marc (Brussels, BE), Schreier; Peter (Cologne, DE), Schell; Jeff (Cologne, DE), Bohnert; Hans J. (Tucson, AZ), Cash more; Anthony R. (Woodside, NY), Timko; Michael P. (New York, NY), Kausch; Albert P. (Durham, NH) |
| Assignee: | Plant Genetic Systems, N.V. (Brussels, BE) Bayer A.G. (Lever Kusen, DE) |
| Application Number: | 08/468,317 |
| Patent Claims: | see list of patent claims |
Details for Patent 6,063,601
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Number | Approval Date | Patent No. | Assignee | Estimated Patent Expiration | Status | Orphan | Source |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Schering | INTRON A | interferon alfa-2b | VIAL | 103132 | 001 | 1986-06-04 | Start Trial | Plant Genetic Systems, N.V. (Brussels, BE) Bayer A.G. (Lever Kusen, DE) | 2017-05-16 | RX | search | |
| Schering | INTRON A | interferon alfa-2b | VIAL | 103132 | 002 | 1986-06-04 | Start Trial | Plant Genetic Systems, N.V. (Brussels, BE) Bayer A.G. (Lever Kusen, DE) | 2017-05-16 | RX | search | |
| Schering | INTRON A | interferon alfa-2b | VIAL | 103132 | 003 | 1986-06-04 | Start Trial | Plant Genetic Systems, N.V. (Brussels, BE) Bayer A.G. (Lever Kusen, DE) | 2017-05-16 | RX | search | |
| >Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Number | >Approval Date | >Patent No. | >Assignee | >Estimated Patent Expiration | >Status | >Orphan | >Source |
